![]() ![]() The new investment puts RETORTE in a position to tap the sub-markets for selenite and selenate – used as a trace element in many consumer goods including table salt, vitamin products, and immune sprays – even more effectively. This certified industry standard requires a closed production cycle that eliminates any impurities and guarantees the absolute purity of the processes. In addition to other industries, food and pharmaceuticals offer excellent growth potential for RETORTE that GMP-compliant production will secure and expand. The highest food and pharmaceutical industry standards in keeping with good manufacturing practice “With this investment in the new production plant, we are strengthening RETORTE’s market position and enabling additional, global growth.” It turns raw selenium, a by-product of copper smelting, into valuable selenium products and markets them profitably,” Aurubis CFO Rainer Verhoeven explained at the groundbreaking. “For years now, RETORTE has successfully operated in the niche market of selenium production and is an important building block in our multimetal material cycle. This investment of around € 7 million is a sign of multimetal producer Aurubis’ commitment to further expanding RETORTE’s profitable selenium business in the food and pharmaceutical industries and positioning the German site for the future. The plant will expand selenium production in keeping with “good manufacturing practice” (GMP) starting in mid-2025. Röthenbach, J– Today marked the groundbreaking for the construction of a state-of-the-art production plant at Aurubis subsidiary RETORTE in Röthenbach a.d.Pegnitz.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |